Study guide

8.2 Infectious Pneumonias & Pleural Effusions

USMLE Step 2 CK Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Human Development & Well-Patient Care

1.1 Infant, Child & Adolescent Development & Growth 1.2 Adult Development, Aging & Geriatric Assessment 1.3 Preventive Health, Immunization & Well-Patient Screening

2 Chapter 2: Immune System & Immunologic Disorders

2.1 Primary & Secondary Immunodeficiencies 2.2 Hypersensitivity Reactions, Allergy & Anaphylaxis 2.3 Autoimmune & Rheumatologic Disease Principles

3 Chapter 3: Blood & Lymphoreticular System

3.1 Anemias: Microcytic, Normocytic & Macrocytic Etiologies 3.2 Bleeding Disorders, Coagulopathies & Platelet Pathology 3.3 Hematologic Malignancies & Lymphoproliferative Disorders

4 Chapter 4: Behavioral Health & Psychiatric Disorders

4.1 Mood Disorders: Major Depression & Bipolar Spectrum 4.2 Anxiety, Trauma-Related & Somatic Symptom Disorders 4.3 Psychotic Disorders & Schizophrenia Spectrum 4.4 Substance Use Disorders & Psychopharmacology

5 Chapter 5: Nervous System & Special Senses

5.1 Cerebrovascular Disease, Stroke & Transients 5.2 Seizures, Epilepsy & Altered Mental Status 5.3 Movement Disorders, Dementia & Peripheral Neuropathies 5.4 Special Senses: Ophthalmologic & Otolaryngologic Emergencies

6 Chapter 6: Musculoskeletal System & Dermatology

6.1 Fractures, Dislocations & Orthopedic Trauma 6.2 Inflammatory Arthropathies & Crystal-Induced Diseases 6.3 Inflammatory & Infectious Dermatoses 6.4 Cutaneous Malignancies & Blistering Disorders

7 Chapter 7: Cardiovascular System

7.1 Coronary Artery Disease & Acute Coronary Syndromes 7.2 Heart Failure, Cardiomyopathies & Valvular Disease 7.3 Cardiac Arrhythmias, Conduction Blocks & EKG Interpretation 7.4 Vascular Emergencies: Aortic Aneurysms & Peripheral Arterial Disease

8 Chapter 8: Respiratory System

8.1 Obstructive Airway Diseases: Asthma & COPD 8.2 Infectious Pneumonias & Pleural Effusions 8.3 Pulmonary Vascular Disease & Thromboembolism 8.4 Acute Respiratory Distress Syndrome & Interstitial Lung Diseases

9 Chapter 9: Gastrointestinal System

9.1 Esophageal, Gastric & Peptic Ulcer Disorders 9.2 Inflammatory Bowel Disease & Colorectal Neoplasms 9.3 Hepatic Disorders, Cirrhosis & Portal Hypertension 9.4 Biliary Tract Diseases & Pancreatitis

10 Chapter 10: Renal, Urinary & Reproductive Systems

10.1 Acute Kidney Injury & Chronic Kidney Disease 10.2 Glomerular & Tubulointerstitial Diseases 10.3 Nephrolithiasis, Urinary Tract Infections & Prostate Pathology 10.4 Fluid, Electrolyte & Acid-Base Disorders 10.5 Female Reproductive Disorders & Gynecology 10.6 Breast Pathology & Clinical Breast Disease

11 Chapter 11: Pregnancy, Childbirth & Puerperium

11.1 Normal Prenatal Care & Maternal-Fetal Physiology 11.2 Medical & Obstetric Complications of Pregnancy 11.3 Labor, Delivery & Postpartum Management

12 Chapter 12: Endocrine System

12.1 Diabetes Mellitus, Hypoglycemia & Metabolic Emergencies 12.2 Thyroid & Parathyroid Disorders 12.3 Adrenal & Pituitary Axis Pathology

13 Chapter 13: Multisystem Processes & Critical Care

13.1 Shock States, Sepsis & Systemic Inflammatory Response 13.2 Environmental Emergencies, Toxicology & Overdose 13.3 Infectious Disease Principles & Systemic Pathogens

14 Chapter 14: Biostatistics, Epidemiology & Literature Interpretation

14.1 Study Designs, Bias & Validity 14.2 Diagnostic Testing: Sensitivity, Specificity, PPV & NPV 14.3 Statistical Significance, Risk Measures & Evidence-Based Medicine

15 Chapter 15: Social Sciences, Ethics & Systems-Based Practice

15.1 Medical Ethics, Informed Consent & Patient Autonomy 15.2 Legal Issues, Confidentiality & Surrogate Decision Making 15.3 Patient Safety, Quality Improvement & Medical Error Analysis 15.4 Health Care Delivery Systems, Interprofessional Care & Transitions

8.2 Infectious Pneumonias & Pleural Effusions

Key Takeaways Explain This Topic AI

CURB-65 score risk-stratifies CAP: scores 0-1 are managed outpatient, score 2 inpatient medical ward, and scores ≥3 require ICU admission.

Atypical pneumonias present with indolent systemic symptoms and extrapulmonary signs (e.g., Legionella with hyponatremia and diarrhea; Mycoplasma with cold agglutinins and erythema multiforme).

Hospital-Acquired Pneumonia (HAP) occurs >48 hours after admission and requires empiric dual coverage against Pseudomonas aeruginosa and MRSA.

Light's criteria classifies pleural fluid as exudative if pleural/serum protein > 0.5, pleural/serum LDH > 0.6, or pleural LDH > 2/3 ULN serum LDH; transudates stem from hydrostatic/oncotic pressure imbalances.

Complicated parapneumonic effusions and empyemas (pH < 7.20, glucose < 60 mg/dL, positive Gram stain/culture, or frank pus) mandate tube thoracostomy drainage alongside systemic antibiotics.

Last updated: July 2026

8.2 Infectious Pneumonias & Pleural Effusions

Pneumonia and pleural effusions represent major causes of acute pulmonary morbidity. On USMLE Step 2 CK, key competencies include identifying specific etiologic pathogens from clinical vignettes, applying risk-stratification algorithms (CURB-65) for community-acquired pneumonia, differentiating hospital-acquired from aspiration syndromes, and using Light's criteria to guide pleural effusion management.

Community-Acquired Pneumonia (CAP)

Community-Acquired Pneumonia (CAP) is an acute infection of the pulmonary parenchyma acquired outside of healthcare settings. Pathogens are broadly categorized into typical and atypical bacterial species.

Etiologic Organisms & Clinical Signatures

Streptococcus pneumoniae : The most common cause of CAP overall across all adult age groups. Classic presentation includes acute high fever, rigors, pleuritic chest pain, and productive rust-colored sputum . Radiograph demonstrates classic lobar consolidation.

Mycoplasma pneumoniae : Frequently affects young adults, college students, and military recruits ("walking pneumonia"). Presents with an insidious onset of headache, dry hacking cough, low-grade fever, and diffuse patchy/interstitial infiltrates. Key USMLE associations: IgM cold agglutinins (causing autoimmune hemolytic anemia), erythema multiforme , and bullous myringitis. Treated with macrolides (azithromycin) or doxycycline.

Legionella pneumophila : Acquired via inhalation of aerosolized water from contaminated systems (air conditioners, hotel showers, cruise ships). Characterized by high fever with relative bradycardia (Faget sign), gastrointestinal symptoms ( watery diarrhea , abdominal pain, nausea), and central nervous system abnormalities ( confusion , lethargy). Laboratory testing reveals hyponatremia (SIADH or renal tubular injury) and elevated transaminases. Confirmed by urinary antigen test (detects serogroup 1) or culture on buffered charcoal yeast extract (BCYE) agar. Treated with respiratory fluoroquinolones (levofloxacin, moxifloxacin) or azithromycin.

Klebsiella pneumoniae : Classic pathogen in individuals with alcohol use disorder, diabetes mellitus, or severe aspiration risk. Characterized by necrotizing lobar pneumonia, upper lobe cavitary lesions, and thick, blood-tinged "currant jelly" sputum .

Staphylococcus aureus : Secondary bacterial pneumonia following viral influenza infection ("post-flu pneumonia"). Presents with rapid clinical deterioration, necrotizing parenchymal destruction, cavitating infiltrates, and pneumatoceles (fluid/air-filled thin-walled cysts). High prevalence of MRSA requires empiric vancomycin or linezolid.

Pseudomonas aeruginosa : High risk in patients with structural lung disease ( cystic fibrosis , bronchiectasis ), severe neutropenia, or recent prolonged broad-spectrum antibiotic therapy.

Other Notable Atypicals : Chlamydia pneumoniae (pharyngitis followed by subacute bronchitis/pneumonia), Coxiella burnetii (Q fever, livestock exposure, hepatitis, culture-negative endocarditis), Chlamydia psittaci (Psittacosis, exposure to pet birds/parrots, splenomegaly, macular rash).

CAP Risk Stratification: CURB-65 Score

The CURB-65 score is a validated clinical prediction rule used to determine site-of-care disposition (outpatient vs general ward vs ICU) for patients with CAP.

  • Criterion Points Clinical Definition
  • C onfusion 1 New-onset disorientation to person, place, or time
  • U rea (BUN) 1 BUN > 19 mg/dL (> 7 mmol/L)
  • R espiratory Rate 1 ≥ 30 breaths/min
  • B lood Pressure 1 Systolic BP < 90 mmHg OR Diastolic BP ≤ 60 mmHg
  • Age ≥ 65 1 Age 65 years or older
  • Management Disposition & Empiric Antimicrobial Regimens

Score 0 - 1 : Low risk (<1.5% 30-day mortality); Outpatient management .

Otherwise Healthy : Amoxicillin high-dose (1g TID) OR Doxycycline OR Macrolide (azithromycin/clarithromycin, only if local pneumococcal macrolide resistance is <25%).

Comorbidities (chronic heart, lung, liver, or renal disease; diabetes; alcoholism; malignancy): Monotherapy with Respiratory Fluoroquinolone (Levofloxacin 750 mg daily or Moxifloxacin 400 mg daily) OR Combination Beta-lactam (Amoxicillin-clavulanate or Cefpodoxime) PLUS Macrolide or Doxycycline.

Score 2 : Moderate risk (8.8% mortality); Inpatient general medical ward .

Empiric Regimen : IV Beta-lactam (Ceftriaxone 1-2g daily, Cefotaxime, or Ampicillin-sulbactam) PLUS IV/PO Macrolide (Azithromycin) OR Respiratory Fluoroquinolone monotherapy.

Score ≥ 3 : High risk (up to 30% mortality); Intensive Care Unit (ICU) admission.

Empiric Regimen : IV Beta-lactam (Ceftriaxone 2g daily or Ampicillin-sulbactam) PLUS IV Azithromycin OR IV Beta-lactam PLUS IV Respiratory Fluoroquinolone.

MRSA Risk : Add IV Vancomycin or IV Linezolid.

Pseudomonas Risk : Substitute Beta-lactam with Cefepime, Piperacillin-tazobactam, or Meropenem.

Hospital-Acquired (HAP) vs Ventilator-Associated (VAP) Pneumonia

Hospital-Acquired Pneumonia (HAP) : Pneumonia occurring >48 hours after hospital admission that was not incubating at the time of admission.

Ventilator-Associated Pneumonia (VAP) : Pneumonia developing >48 hours after endotracheal intubation .

Microbiology : High prevalence of multidrug-resistant (MDR) pathogens, predominantly Pseudomonas aeruginosa , MRSA , Acinetobacter baumannii , and enteric gram-negative bacilli.

Empiric Regimen : Dual antipseudomonal coverage + MRSA coverage:

Antipseudomonal Beta-lactam : Cefepime, Piperacillin-tazobactam, or Meropenem.

Second Antipseudomonal Agent : Ciprofloxacin, Levofloxacin, or Amikacin/Gentamicin.

Anti-MRSA Agent : Vancomycin or Linezolid.

Aspiration Pneumonia vs Aspiration Pneumonitis

Aspiration syndromes result from inhalation of gastric contents or oropharyngeal secretions. Differentiating chemical inflammation from active bacterial infection is critical to prevent unnecessary antibiotic use.

Feature Aspiration Pneumonitis Aspiration Pneumonia

Pathophysiology Chemical inflammation caused by aspirated sterile gastric acid Infectious parenchymal inflammation caused by oral anaerobes + aerobes

Risk Factors Depressed consciousness (anesthesia, drug overdose, seizures) Dysphagia, stroke, alcohol intoxication, periodontal disease, altered mental status

Onset Sudden, within hours of aspiration event Insidious, 24 to 72 hours after aspiration event

Signs/Symptoms Sudden hypoxemia, fever, diffuse bilateral crackles, bronchospasm Fever, cough, productive foul-smelling sputum , localized consolidation

Treatment Supportive care only (antibiotics are NOT indicated initially) Antibiotics required : Ampicillin-sulbactam (IV) or Amoxicillin-clavulanate (PO); Clindamycin for penicillin allergy

Anatomic Site Dependent segments: Superior segment of RLL (supine) or Posterior segment of RUL Dependent lung segments (Right lower lobe superior segment most common overall)

Pleural Effusions: Transudates vs Exudates & Light's Criteria

A pleural effusion is an abnormal collection of fluid in the pleural space. Diagnostic thoracentesis is indicated for new, unexplained effusions >1 cm on lateral decubitus radiograph or bedside ultrasound (except in typical bilateral congestive heart failure, where a trial of diuretic therapy is initiated first).

Light's Criteria Pathophysiology

An effusion is classified as an EXUDATE if AT LEAST ONE of the following three criteria is met:

  • Pleural Fluid Protein / Serum Protein ratio > 0.5
  • Pleural Fluid LDH / Serum LDH ratio > 0.6
  • Pleural Fluid LDH > 2/3 the Upper Limit of Normal for serum LDH

If NONE of these criteria are met, the effusion is classified as a TRANSUDATE .

Pathophysiologic Mechanisms

Transudative Effusions : Result from systemic factors altering hydrostatic or oncotic pressures across intact pleural capillary membranes.

Increased Hydrostatic Pressure : Congestive Heart Failure (most common transudate overall).

Decreased Oncotic Pressure : Cirrhosis (hepatic hydrothorax), Nephrotic Syndrome, severe Hypoalbuminemia/malnutrition.

Exudative Effusions : Result from local inflammatory processes that increase pleural capillary permeability or cause lymphatic obstruction.

Increased Capillary Permeability : Infections (parapneumonic effusion, Tuberculosis), Malignancy (lung, breast, lymphoma), Pulmonary Embolism, Autoimmune diseases (Rheumatoid Arthritis, Systemic Lupus Erythematosus), Post-cardiac injury syndrome (Dressler syndrome).

Parapneumonic Effusions & Empyema Management

Parapneumonic effusions accompany bacterial pneumonia and exist along a clinical continuum requiring distinct management strategies.

  • Classification Pleural Fluid pH Glucose (mg/dL) LDH (U/L) Gram Stain / Culture Clinical Management
  • Uncomplicated Parapneumonic > 7.20 > 60 < 1000 Negative Systemic Antibiotics alone
  • Complicated Parapneumonic < 7.20 < 60 > 1000 Negative Chest Tube Thoracostomy Drainage + Antibiotics

Empyema < 7.20 < 60 Variable Positive or Frank Pus Chest Tube Thoracostomy Drainage + Antibiotics ± Intrapleural Fibrinolytics / VATS

Management Nuances

Chest Tube Drainage Indications : Pleural fluid pH < 7.20, pleural glucose < 60 mg/dL, positive Gram stain or culture, or frank purulent fluid (empyema).

Loculated or Refractory Empyema : When chest tube drainage is incomplete due to pleural loculations, intrapleural fibrinolytics (tissue plasminogen activator [tPA] combined with recombinant human DNase) or surgical Video-Assisted Thoracoscopic Surgery (VATS) decortication is indicated.